[Cardiorenal syndrome in diabetes mellitus: risk factors and developmental mechanisms]

M V Shestakova1, I R Yarek-Martynova1, N S Ivanishina2

  • 1Endocrinology Research Centre.

Problemy Endokrinologii
|October 20, 2019
PubMed

Insights

Kidney damage significantly accelerates cardiovascular disease progression, independent of traditional risk factors. This highlights the critical link between kidney health and heart disease, termed cardiorenal syndrome.

Area of Science:

  • Cardiology
  • Nephrology
  • Vascular Biology

Context:

  • Cardiorenal syndrome links cardiovascular and kidney pathologies.
  • Recent research emphasizes kidney disease as an independent atherosclerosis risk factor.
  • Traditional risk factors alone do not explain accelerated vascular changes in cardiorenal syndrome.

Purpose:

  • To define cardiorenal syndrome and its emerging significance.
  • To highlight the role of kidney pathology in atherosclerosis progression.
  • To underscore the inadequacy of traditional risk factors in explaining cardiorenal disease.

Summary:

  • Kidney damage causally associates with cardiovascular system pathology, defining cardiorenal syndrome.
  • Kidney pathology independently accelerates atherosclerotic vascular changes.
  • This progression exceeds explanations based solely on arterial hypertension, dyslipidemia, obesity, or smoking.

Impact:

  • Establishes kidney health as a crucial factor in cardiovascular disease management.
  • Promotes a more integrated approach to treating patients with co-existing heart and kidney conditions.
  • Advances understanding of atherosclerosis beyond conventional risk factors.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
837
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
529
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
867
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
514
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K